A citation-based method for searching scientific literature

Radia M Johnson, Heidi S Phillips, Carlos Bais, Cameron W Brennan, Timothy F Cloughesy, Anneleen Daemen, Ulrich Herrlinger, Robert B Jenkins, Albert Lai, Christoph Mancao, Michael Weller, Wolfgang Wick, Richard Bourgon, Josep Garcia. Neuro Oncol 2020
Times Cited: 5







List of co-cited articles
10 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.
Roel G W Verhaak, Katherine A Hoadley, Elizabeth Purdom, Victoria Wang, Yuan Qi, Matthew D Wilkerson, C Ryan Miller, Li Ding, Todd Golub, Jill P Mesirov,[...]. Cancer Cell 2010
60

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
60

The somatic genomic landscape of glioblastoma.
Cameron W Brennan, Roel G W Verhaak, Aaron McKenna, Benito Campos, Houtan Noushmehr, Sofie R Salama, Siyuan Zheng, Debyani Chakravarty, J Zachary Sanborn, Samuel H Berman,[...]. Cell 2013
40

Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial.
David A Reardon, Alba A Brandes, Antonio Omuro, Paul Mulholland, Michael Lim, Antje Wick, Joachim Baehring, Manmeet S Ahluwalia, Patrick Roth, Oliver Bähr,[...]. JAMA Oncol 2020
207
40

MGMT gene silencing and benefit from temozolomide in glioblastoma.
Monika E Hegi, Annie-Claire Diserens, Thierry Gorlia, Marie-France Hamou, Nicolas de Tribolet, Michael Weller, Johan M Kros, Johannes A Hainfellner, Warren Mason, Luigi Mariani,[...]. N Engl J Med 2005
40

An integrated genomic analysis of human glioblastoma multiforme.
D Williams Parsons, Siân Jones, Xiaosong Zhang, Jimmy Cheng-Ho Lin, Rebecca J Leary, Philipp Angenendt, Parminder Mankoo, Hannah Carter, I-Mei Siu, Gary L Gallia,[...]. Science 2008
40

cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV".
Daniel J Brat, Kenneth Aldape, Howard Colman, Eric C Holland, David N Louis, Robert B Jenkins, B K Kleinschmidt-DeMasters, Arie Perry, Guido Reifenberger, Roger Stupp,[...]. Acta Neuropathol 2018
297
40

IDH1 and IDH2 mutations in gliomas.
Hai Yan, D Williams Parsons, Genglin Jin, Roger McLendon, B Ahmed Rasheed, Weishi Yuan, Ivan Kos, Ines Batinic-Haberle, Siân Jones, Gregory J Riggins,[...]. N Engl J Med 2009
40

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016.
Quinn T Ostrom, Gino Cioffi, Haley Gittleman, Nirav Patil, Kristin Waite, Carol Kruchko, Jill S Barnholtz-Sloan. Neuro Oncol 2019
702
40

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.
Roger Stupp, Warren P Mason, Martin J van den Bent, Michael Weller, Barbara Fisher, Martin J B Taphoorn, Karl Belanger, Alba A Brandes, Christine Marosi, Ulrich Bogdahn,[...]. N Engl J Med 2005
40

Histologically defined intratumoral sequencing uncovers evolutionary cues into conserved molecular events driving gliomagenesis.
Antony Prabhu, Pravin Kesarwani, Shiva Kant, Stewart F Graham, Prakash Chinnaiyan. Neuro Oncol 2017
16
20

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.
Heidi S Phillips, Samir Kharbanda, Ruihuan Chen, William F Forrest, Robert H Soriano, Thomas D Wu, Anjan Misra, Janice M Nigro, Howard Colman, Liliana Soroceanu,[...]. Cancer Cell 2006
20

Irradiation promotes an m2 macrophage phenotype in tumor hypoxia.
Chi-Shiun Chiang, Sheng Yung Fu, Shu-Chi Wang, Ching-Fang Yu, Fang-Hsin Chen, Chi-Min Lin, Ji-Hong Hong. Front Oncol 2012
119
20

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells.
D I Gabrilovich, H L Chen, K R Girgis, H T Cunningham, G M Meny, S Nadaf, D Kavanaugh, D P Carbone. Nat Med 1996
20

Cancer stem cells in glioblastoma.
Justin D Lathia, Stephen C Mack, Erin E Mulkearns-Hubert, Claudia L L Valentim, Jeremy N Rich. Genes Dev 2015
734
20

Hypoxia-inducible factor-2alpha (HIF-2alpha) is involved in the apoptotic response to hypoglycemia but not to hypoxia.
K Brusselmans, F Bono, P Maxwell, Y Dor, M Dewerchin, D Collen, J M Herbert, P Carmeliet. J Biol Chem 2001
82
20

Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages.
Teresa E Peterson, Nathaniel D Kirkpatrick, Yuhui Huang, Christian T Farrar, Koen A Marijt, Jonas Kloepper, Meenal Datta, Zohreh Amoozgar, Giorgio Seano, Keehoon Jung,[...]. Proc Natl Acad Sci U S A 2016
166
20

Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival.
Jonas Kloepper, Lars Riedemann, Zohreh Amoozgar, Giorgio Seano, Katharina Susek, Veronica Yu, Nisha Dalvie, Robin L Amelung, Meenal Datta, Jonathan W Song,[...]. Proc Natl Acad Sci U S A 2016
181
20

Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance.
Brian B Liau, Cem Sievers, Laura K Donohue, Shawn M Gillespie, William A Flavahan, Tyler E Miller, Andrew S Venteicher, Christine H Hebert, Christopher D Carey, Scott J Rodig,[...]. Cell Stem Cell 2017
192
20

Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors.
Gregory T Motz, Stephen P Santoro, Li-Ping Wang, Tom Garrabrant, Ricardo R Lastra, Ian S Hagemann, Priti Lal, Michael D Feldman, Fabian Benencia, George Coukos. Nat Med 2014
441
20

Genomic correlates of response to immune checkpoint blockade.
Tanya E Keenan, Kelly P Burke, Eliezer M Van Allen. Nat Med 2019
167
20

Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escape.
Emmanuelle di Tomaso, Matija Snuderl, Walid S Kamoun, Dan G Duda, Pavan K Auluck, Ladan Fazlollahi, Ovidiu C Andronesi, Matthew P Frosch, Patrick Y Wen, Scott R Plotkin,[...]. Cancer Res 2011
138
20

Glioblastoma-activated pericytes support tumor growth via immunosuppression.
Isadora F G Sena, Ana E Paiva, Pedro H D M Prazeres, Patrick O Azevedo, Luiza Lousado, Sujit K Bhutia, Alla B Salmina, Akiva Mintz, Alexander Birbrair. Cancer Med 2018
36
20

PHD3 regulates EGFR internalization and signalling in tumours.
Boyan K Garvalov, Franziska Foss, Anne-Theres Henze, Ioanna Bethani, Sabine Gräf-Höchst, Devendra Singh, Alina Filatova, Higinio Dopeso, Sascha Seidel, Miriam Damm,[...]. Nat Commun 2014
36
20

Targeting Glioma Stem Cell-Derived Pericytes Disrupts the Blood-Tumor Barrier and Improves Chemotherapeutic Efficacy.
Wenchao Zhou, Cong Chen, Yu Shi, Qiulian Wu, Ryan C Gimple, Xiaoguang Fang, Zhi Huang, Kui Zhai, Susan Q Ke, Yi-Fang Ping,[...]. Cell Stem Cell 2017
87
20

Limited role for transforming growth factor-β pathway activation-mediated escape from VEGF inhibition in murine glioma models.
Davide Mangani, Michael Weller, Emad Seyed Sadr, Edith Willscher, Katharina Seystahl, Guido Reifenberger, Ghazaleh Tabatabai, Hans Binder, Hannah Schneider. Neuro Oncol 2016
20
20

European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas.
Michael Weller, Martin van den Bent, Jörg C Tonn, Roger Stupp, Matthias Preusser, Elizabeth Cohen-Jonathan-Moyal, Roger Henriksson, Emilie Le Rhun, Carmen Balana, Olivier Chinot,[...]. Lancet Oncol 2017
484
20

Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases.
Sophia Frentzas, Eve Simoneau, Victoria L Bridgeman, Peter B Vermeulen, Shane Foo, Eleftherios Kostaras, Mark Nathan, Andrew Wotherspoon, Zu-Hua Gao, Yu Shi,[...]. Nat Med 2016
187
20

Plerixafor injection: a hematopoietic stem cell mobilizer in non-Hodgkin lymphoma and multiple myeloma.
Esa Jantunen, Ville Varmavuo, Jaakko Valtola. Expert Rev Hematol 2016
8
20

De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors.
Anna Johansson-Percival, Bo He, Zhi-Jie Li, Alva Kjellén, Karen Russell, Ji Li, Irma Larma, Ruth Ganss. Nat Immunol 2017
96
20

An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates.
Jermaine Goveia, Katerina Rohlenova, Federico Taverna, Lucas Treps, Lena-Christin Conradi, Andreas Pircher, Vincent Geldhof, Laura P M H de Rooij, Joanna Kalucka, Liliana Sokol,[...]. Cancer Cell 2020
75
20

Inhibition of notch signaling in glioblastoma targets cancer stem cells via an endothelial cell intermediate.
Koos E Hovinga, Fumiko Shimizu, Rong Wang, Georgia Panagiotakos, Maartje Van Der Heijden, Hamideh Moayedpardazi, Ana Sofia Correia, Denis Soulet, Tamara Major, Jayanthi Menon,[...]. Stem Cells 2010
179
20


Bevacizumab Reduces Permeability and Concurrent Temozolomide Delivery in a Subset of Patients with Recurrent Glioblastoma.
Elizabeth R Gerstner, Kyrre E Emblem, Ken Chang, Bella Vakulenko-Lagun, Yi-Fen Yen, Andrew L Beers, Jorg Dietrich, Scott R Plotkin, Ciprian Catana, Jacob M Hooker,[...]. Clin Cancer Res 2020
26
20

Targeting glioma stem cells through combined BMI1 and EZH2 inhibition.
Xun Jin, Leo J Y Kim, Qiulian Wu, Lisa C Wallace, Briana C Prager, Tanwarat Sanvoranart, Ryan C Gimple, Xiuxing Wang, Stephen C Mack, Tyler E Miller,[...]. Nat Med 2017
164
20

A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha.
Sascha Seidel, Boyan K Garvalov, Valtteri Wirta, Louise von Stechow, Anne Schänzer, Konstantinos Meletis, Marietta Wolter, Daniel Sommerlad, Anne-Theres Henze, Monica Nistér,[...]. Brain 2010
300
20

Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa.
Kabir A Khan, Robert S Kerbel. Nat Rev Clin Oncol 2018
183
20


Cooperation of oncolytic virotherapy with VEGF-neutralizing antibody treatment in IDH wildtype glioblastoma depends on MMP9.
Hans-Georg Wirsching, Sonali Arora, Huajia Zhang, Frank Szulzewsky, Patrick J Cimino, Christophe Quéva, A McGarry Houghton, Joseph C Glorioso, Michael Weller, Eric C Holland. Neuro Oncol 2019
5
20

Clonal evolution of glioblastoma under therapy.
Jiguang Wang, Emanuela Cazzato, Erik Ladewig, Veronique Frattini, Daniel I S Rosenbloom, Sakellarios Zairis, Francesco Abate, Zhaoqi Liu, Oliver Elliott, Yong-Jae Shin,[...]. Nat Genet 2016
336
20

T cell exclusion, immune privilege, and the tumor microenvironment.
Johanna A Joyce, Douglas T Fearon. Science 2015
945
20

VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2.
N G Gavalas, M Tsiatas, O Tsitsilonis, E Politi, K Ioannou, A C Ziogas, A Rodolakis, G Vlahos, N Thomakos, D Haidopoulos,[...]. Br J Cancer 2012
78
20

A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment.
Amelie Griveau, Giorgio Seano, Samuel J Shelton, Robert Kupp, Arman Jahangiri, Kirsten Obernier, Shanmugarajan Krishnan, Olle R Lindberg, Tracy J Yuen, An-Chi Tien,[...]. Cancer Cell 2018
93
20

Single-Cell Transcriptome Analyses Reveal Endothelial Cell Heterogeneity in Tumors and Changes following Antiangiogenic Treatment.
Qi Zhao, Alexandra Eichten, Asma Parveen, Christina Adler, Ying Huang, Wei Wang, Yueming Ding, Alexander Adler, Thomas Nevins, Min Ni,[...]. Cancer Res 2018
77
20

Attenuating hypoxia driven malignant behavior in glioblastoma with a novel hypoxia-inducible factor 2 alpha inhibitor.
Jaclyn J Renfrow, Michael H Soike, James L West, Shakti H Ramkissoon, Linda Metheny-Barlow, Ryan T Mott, Carol A Kittel, Ralph B D'Agostino, Stephen B Tatter, Adrian W Laxton,[...]. Sci Rep 2020
6
20

Advances in the molecular genetics of gliomas - implications for classification and therapy.
Guido Reifenberger, Hans-Georg Wirsching, Christiane B Knobbe-Thomsen, Michael Weller. Nat Rev Clin Oncol 2017
259
20


Glioblastoma progression is assisted by induction of immunosuppressive function of pericytes through interaction with tumor cells.
Rut Valdor, David García-Bernal, Carlos Bueno, Mónica Ródenas, José M Moraleda, Fernando Macian, Salvador Martínez. Oncotarget 2017
32
20

Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy.
Kyrre E Emblem, Kim Mouridsen, Atle Bjornerud, Christian T Farrar, Dominique Jennings, Ronald J H Borra, Patrick Y Wen, Percy Ivy, Tracy T Batchelor, Bruce R Rosen,[...]. Nat Med 2013
143
20

Brain immunology and immunotherapy in brain tumours.
John H Sampson, Michael D Gunn, Peter E Fecci, David M Ashley. Nat Rev Cancer 2020
111
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.